Personalizing induction therapy in kidney transplantation

Meredith J. Aull, Manikkam Suthanthiran

Research output: Contribution to journalShort survey

2 Citations (Scopus)

Abstract

Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.

Original languageEnglish
Pages (from-to)619-620
Number of pages2
JournalNature Reviews Nephrology
Volume5
Issue number11
DOIs
Publication statusPublished - 1 Nov 2009
Externally publishedYes

Fingerprint

Kidney Transplantation
Kidney
Antilymphocyte Serum
Immunosuppressive Agents
Rabbits
Therapeutics
Transplant Recipients
daclizumab

ASJC Scopus subject areas

  • Medicine(all)
  • Nephrology

Cite this

Personalizing induction therapy in kidney transplantation. / Aull, Meredith J.; Suthanthiran, Manikkam.

In: Nature Reviews Nephrology, Vol. 5, No. 11, 01.11.2009, p. 619-620.

Research output: Contribution to journalShort survey

@article{d399d200d950435d818b80f310d72b20,
title = "Personalizing induction therapy in kidney transplantation",
abstract = "Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.",
author = "Aull, {Meredith J.} and Manikkam Suthanthiran",
year = "2009",
month = "11",
day = "1",
doi = "10.1038/nrneph.2009.164",
language = "English",
volume = "5",
pages = "619--620",
journal = "Nature Reviews Nephrology",
issn = "1759-5061",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Personalizing induction therapy in kidney transplantation

AU - Aull, Meredith J.

AU - Suthanthiran, Manikkam

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.

AB - Induction therapy with rabbit anti-thymocyte globulin is preferable to induction with daclizumab in renal transplant recipients at high immunological risk. These findings provide additional support to the idea that personalized immunosuppressive regimens should be developed in renal transplant recipients.

UR - http://www.scopus.com/inward/record.url?scp=70350515660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350515660&partnerID=8YFLogxK

U2 - 10.1038/nrneph.2009.164

DO - 10.1038/nrneph.2009.164

M3 - Short survey

VL - 5

SP - 619

EP - 620

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

SN - 1759-5061

IS - 11

ER -